Manufacture of other chemical products n.e.c.
EPAX NORWAY AS
Revenue 2024
NOK 859.8m
Operating profit
NOK 137.2m
Equity
NOK 449.5m
Incorporated
2005
Employees
75
Share capital
NOK 4.2m
Varemerker (10)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| EQP + TECH | 202216355 | 325198 | Registrert | 2023-01-19 | 2032-12-01 |
| EQP + TECH EPAX QUALITY PROCESS TECHNOLOGY | 202216356 | 325196 | Registrert | 2023-01-19 | 2032-12-01 |
| EPAX MARINE OMEGA-3 FORMULA | 200703757 | 241013 | Registrering opphørt | 2017-09-25 | 2017-09-25 |
| Epax | 201314682 | 275132 | Registrert | 2014-03-21 | 2033-12-04 |
| OceanSilver | 201310341 | 273402 | Registrert | 2013-12-03 | 2033-08-21 |
| EPAX | 200703756 | 241012 | Registrert | 2007-09-25 | 2027-09-25 |
| OLUF HOLM LTD. | 199805070 | 198622 | Registrert | 1999-07-29 | 2029-07-29 |
| THE PEDER DEVOLD OIL COMPANY LTD. | 199805071 | 198623 | Registrert | 1999-07-29 | 2029-07-29 |
| LIPROMEGA | 19970986 | 193741 | Registrert | 1998-10-22 | 2028-10-22 |
| EPAX | 19911241 | 155173 | Registrert | 1993-02-18 | 2033-02-18 |
Source: Patentstyret
Patenter (5)
| Title | Application no. | Patent no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| Very long chain fatty acids for use in mineralization | 20230466 | 349080 | Meddelt | 2025-09-15 | 2043-04-26 |
| Cetoleic acid composition | 20220910 | 348700 | Meddelt | 2025-05-05 | 2042-08-25 |
| Cetoleic acid composition | 20250346 | – | Under behandling | 2025-03-31 | – |
| Composition for treatment of dry eye disease and meibomianitis | 20180849 | 345574 | Meddelt | 2021-04-26 | 2038-06-19 |
| Very long chain fatty acids | 20181574 | – | Endelig henlagt | 2020-09-11 | – |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.